Kymera Therapeutics, Inc. (KYMR)
Data as of , from SEC Form 4 filings.
See up to 3 months of KYMR. The 7-day demo opens the 1M and 3M ranges and puts KYMR on your watchlist.
Start 7-day demoLatest KYMR insider trades
About Kymera Therapeutics, Inc. (KYMR)
Kymera Therapeutics, Inc. is an SEC registrant, filing under CIK 0001815442, classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
KYMR Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 9 | 36,371 | $4.16M |
| Grant or award | 2 | 114,000 | |
| Option exercise | 2 | 60,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
KYMR insider transactions (Form 4)
3170 Form 4 filings on record, the earliest from Dec 2, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Jared Gollob - Officer | Option exercise | Stock Option (Right to Buy) | 800 | $0.00 | - | |
| Jared Gollob - Officer | Option exercise | Stock Option (Right to Buy) | 673 | $0.00 | - | |
| Jared Gollob - Officer | Option exercise | Common Stock | 800 | $1.31 | $1K | |
| Jared Gollob - Officer | Option exercise | Common Stock | 673 | $2.08 | $1K | |
| Jared Gollob - Officer | Open-market sale | Common Stock | 3,114 | $60.00 | $187K | |
 Jeffrey W. Albers | Option exercise | Common Stock | 5,000 | $10.34 | $52K | |
| Jeffrey W. Albers | Open-market sale | Common Stock | 5,000 | $59.19 footnote F2 | $296K | |
| Jeffrey W. Albers | Option exercise | Stock Option (Right to Buy) | 5,000 | $0.00 | - | |
| ||||||
| Bruce N. Jacobs - Officer | Option exercise | Common Stock | 79,220 | $2.08 | $165K | |
| Bruce N. Jacobs - Officer | Open-market sale | Common Stock | 79,220 | $50.00 | $3.96M | |
| Bruce N. Jacobs - Officer | Option exercise | Stock Option (Right to Buy) | 42,246 | $0.00 | - | |
| Bruce N. Jacobs - Officer | Option exercise | Stock Option (Right to Buy) | 36,974 | $0.00 | - | |
| Nello Mainolfi - Officer | Option exercise | Common Stock | 30,000 | $2.08 | $62K | |
| Nello Mainolfi - Officer | Open-market sale | Common Stock | 30,000 | $49.00 | $1.47M | |
| Nello Mainolfi - Officer | Option exercise | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Brian Adams - Officer | Grant or award | Common Stock | 52,500 | $0.00 | - | |
| Brian Adams - Officer | Grant or award | Stock Option (Right to Buy) | 105,000 | $0.00 | - | |
| BVF PARTNERS L P - Director | Open-market purchase | Common Stock, $0.0001 par value | 142,604 | $44.00 | $6.27M | |
| BVF PARTNERS L P - Director | Open-market purchase | Common Stock, $0.0001 par value | 115,783 | $44.00 | $5.09M | |
| BVF PARTNERS L P - Director | Open-market purchase | Common Stock, $0.0001 par value | 58,780 | $44.00 | $2.59M | |
| BVF PARTNERS L P - Director | Grant or award | Stock Option (Right to Buy) | 16,000 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Open-market purchase | Common Stock | 55,191 | $44.00 | $2.43M | |
| BAKER BROS. ADVISORS LP | Open-market purchase | Common Stock | 600,309 | $44.00 | $26.41M | |
| BAKER BROS. ADVISORS LP | Open-market purchase | Prefunded Warrants | 55,191 | $44.00 | $2.43M | |
| BAKER BROS. ADVISORS LP | Open-market purchase | Prefunded Warrants | 600,309 | $44.00 | $26.41M | |
| John Maraganore | Grant or award | Stock Option (Right to Buy) | 16,000 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non-Qualified Stock Option (right to buy) | 16,000 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non-Qualified Stock Option (right to buy) | 16,000 | $0.00 | - | |
| Pamela Esposito | Option exercise | Common Stock | 2,500 | $29.55 | $74K | |
| Pamela Esposito | Open-market sale | Common Stock | 2,500 | $49.00 | $123K | |
| Pamela Esposito | Option exercise | Stock Option (Right to Buy) | 2,500 | $0.00 | - | |
Recent KYMR Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Mainolfi Nello | Officer, Director | 30,000 | $3.35M | View on EDGAR | |
| Brian Adams | Officer | 6,371 |
KYMR insider trading FAQ
What is the latest insider trade for KYMR?
Kymera Therapeutics, Inc. (KYMR) had 3 insider filings in the last 90 days, with the most recent on 2026-10-01. The full record for KYMR runs to 70 Form 4 filings, the earliest from 2024-12-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying KYMR stock?
No insider purchases of KYMR were filed in the last 90 days. 9 purchases are on record for this company.
How many insiders are selling KYMR stock?
9 insider sales of KYMR were filed in the last 90 days, totaling $4.16M.
Where can I see KYMR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects KYMR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Nello Mainolfi view on EDGAR
- - Brian Adams view on EDGAR
- - Terence Rooney view on EDGAR
- - Nello Mainolfi view on EDGAR
- - Bruce N. Jacobs view on EDGAR
- - Noah Goodman view on EDGAR
- - Nello Mainolfi view on EDGAR
- - Bruce Booth view on EDGAR
- - Bruce Booth view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where KYMR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow KYMR with a 7-day demo
- KYMR on your watchlist
- Every KYMR Form 4 filing on record
- Up to 3 months of KYMR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
